174 related articles for article (PubMed ID: 19837793)
1. Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia.
Yamamoto S; Nakagawa T; Matsushita Y; Kusano S; Hayashi T; Irokawa M; Aoki T; Korogi Y; Mizoue T
Diabetes Care; 2010 Jan; 33(1):184-9. PubMed ID: 19837793
[TBL] [Abstract][Full Text] [Related]
2. Association of visceral obesity and early colorectal neoplasia.
Choe EK; Kim D; Kim HJ; Park KJ
World J Gastroenterol; 2013 Dec; 19(45):8349-56. PubMed ID: 24363527
[TBL] [Abstract][Full Text] [Related]
3. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.
Kang HW; Kim D; Kim HJ; Kim CH; Kim YS; Park MJ; Kim JS; Cho SH; Sung MW; Jung HC; Lee HS; Song IS
Am J Gastroenterol; 2010 Jan; 105(1):178-87. PubMed ID: 19755965
[TBL] [Abstract][Full Text] [Related]
4. Pulse-wave velocity, the ankle-brachial index, and the visceral fat area are highly associated with colorectal adenoma.
Yamaji Y; Mitsushima T; Koike K
Dig Liver Dis; 2014 Oct; 46(10):943-9. PubMed ID: 24953207
[TBL] [Abstract][Full Text] [Related]
5. IGF-I levels and visceral fat accumulation in colonic neoplasia.
Erarslan E; Coşkun Y; Türkay C; Köktener A; Aydoğan T
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):99-105. PubMed ID: 23954111
[TBL] [Abstract][Full Text] [Related]
6. Visceral Fat Accumulation, Insulin Resistance, and Elevated Depressive Symptoms in Middle-Aged Japanese Men.
Yamamoto S; Matsushita Y; Nakagawa T; Honda T; Hayashi T; Noda M; Mizoue T
PLoS One; 2016; 11(2):e0149436. PubMed ID: 26891344
[TBL] [Abstract][Full Text] [Related]
7. Visceral abdominal fat measured by computed tomography is associated with an increased risk of colorectal adenoma.
Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Aoki T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Noda M; Itoh T; Mizokami M; Uemura N
Int J Cancer; 2014 Nov; 135(10):2273-81. PubMed ID: 24692064
[TBL] [Abstract][Full Text] [Related]
8. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance.
Otake S; Takeda H; Suzuki Y; Fukui T; Watanabe S; Ishihama K; Saito T; Togashi H; Nakamura T; Matsuzawa Y; Kawata S
Clin Cancer Res; 2005 May; 11(10):3642-6. PubMed ID: 15897559
[TBL] [Abstract][Full Text] [Related]
9. Increasing changes in visceral adiposity is associated with higher risk for colorectal adenoma: Multilevel analysis in a prospective cohort.
Moon JM; Im JP; Kim D; Han YM; Soh H; Song JH; Yang SY; Kim YS; Yim JY; Lim SH; Kim JS
J Gastroenterol Hepatol; 2021 Jul; 36(7):1836-1842. PubMed ID: 33300216
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance, central obesity, and risk of colorectal adenomas.
Ortiz AP; Thompson CL; Chak A; Berger NA; Li L
Cancer; 2012 Apr; 118(7):1774-81. PubMed ID: 22009143
[TBL] [Abstract][Full Text] [Related]
11. Visceral obesity as a risk factor for colorectal adenoma occurrence in surveillance colonoscopy.
Im JP; Kim D; Chung SJ; Jin EH; Han YM; Park MJ; Song JH; Yang SY; Kim YS; Yim JY; Lim SH; Kim JS
Gastrointest Endosc; 2018 Jul; 88(1):119-127.e4. PubMed ID: 29510147
[TBL] [Abstract][Full Text] [Related]
12. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat volume and the prevalence of colorectal adenoma.
Yamaji T; Iwasaki M; Sasazuki S; Kurahashi N; Mutoh M; Yamamoto S; Suzuki M; Moriyama N; Wakabayashi K; Tsugane S
Am J Epidemiol; 2009 Dec; 170(12):1502-11. PubMed ID: 19923108
[TBL] [Abstract][Full Text] [Related]
14. The association of the visceral adiposity index with insulin resistance and beta-cell function in Korean adults with and without type 2 diabetes mellitus.
Sung HH; Park CE; Gi MY; Cha JA; Moon AE; Kang JK; Seong JM; Lee JH; Yoon H
Endocr J; 2020 Jun; 67(6):613-621. PubMed ID: 32161204
[TBL] [Abstract][Full Text] [Related]
15. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
17. Association of visceral adiposity and insulin resistance with colorectal adenoma and colorectal cancer.
Jung IS; Shin CM; Park SJ; Park YS; Yoon H; Jo HJ; Kim N; Lee DH
Intest Res; 2019 Jul; 17(3):404-412. PubMed ID: 30419640
[TBL] [Abstract][Full Text] [Related]
18. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.
Miyazaki Y; DeFronzo RA
Cardiovasc Diabetol; 2009 Aug; 8():44. PubMed ID: 19656356
[TBL] [Abstract][Full Text] [Related]
19. Visceral fat accumulation is associated with colorectal cancer in postmenopausal women.
Lee JY; Lee HS; Lee DC; Chu SH; Jeon JY; Kim NK; Lee JW
PLoS One; 2014; 9(11):e110587. PubMed ID: 25402501
[TBL] [Abstract][Full Text] [Related]
20. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
